VAGINAL SQUAMOUS CELL CARCINOMA, NOT OTHERWISE SPECIFIED
Clinical trials for VAGINAL SQUAMOUS CELL CARCINOMA, NOT OTHERWISE SPECIFIED explained in plain language.
Never miss a new study
Get alerted when new VAGINAL SQUAMOUS CELL CARCINOMA, NOT OTHERWISE SPECIFIED trials appear
Sign up with your email to follow new studies for VAGINAL SQUAMOUS CELL CARCINOMA, NOT OTHERWISE SPECIFIED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a drug combo boost survival in advanced cervical cancer?
Disease control OngoingThis study tests whether adding the drug triapine to standard radiation and chemotherapy (cisplatin) helps women with advanced cervical or vaginal cancer live longer. About 450 women with newly diagnosed, bulky stage IB2 to IVA cervical cancer or stage II-IVA vaginal cancer will …
Matched conditions: VAGINAL SQUAMOUS CELL CARCINOMA, NOT OTHERWISE SPECIFIED
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 11:58 UTC
-
Immunotherapy duo takes on 50+ rare cancers in major trial
Disease control OngoingThis phase 2 trial tests a combination of two immunotherapy drugs (nivolumab and ipilimumab) in over 800 people with more than 50 types of rare cancers. The goal is to see if this treatment can shrink tumors by helping the immune system attack cancer cells. The study is for patie…
Matched conditions: VAGINAL SQUAMOUS CELL CARCINOMA, NOT OTHERWISE SPECIFIED
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New drug cocktail offers hope for rare cancers
Disease control OngoingThis study tests a combination of two drugs, atezolizumab and bevacizumab, in people with rare solid tumors that are hard to treat. The goal is to see if the drugs can shrink or control the cancer by boosting the immune system and blocking tumor blood supply. About 133 adults wit…
Matched conditions: VAGINAL SQUAMOUS CELL CARCINOMA, NOT OTHERWISE SPECIFIED
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 11, 2026 20:50 UTC